Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$123.2M
2 rounds on record
Latest round
$61.6M
Venture round · Jun 2020 · 6 yr ago
Team
17
US Form 5500 (plan participants) · Dec 2024
Backers
2
Lightstone Ventures, venBio Partners
The money's age
Long since its last round
75 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2020 | $61.6M | — | SEC Form D |
| Venture round | Jun 2020 | $61.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Tallac Therapeutics, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Hong WanExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
People

Hong Wan
Executive Officer, Director

Christine Brennan
Director

Isaac Cheng
Director

Corey Goodman
Director

Jaume Pons
Director

Michael Carusi
Director

Ran Geng
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Burlingame
United States
HQ
200-500 est. staff

Lightstone Ventures
venBio Partners